Literature DB >> 26824327

Foreign Body Giant Cell-Related Encapsulation of a Synthetic Material Three Years After Augmentation.

Jonas Lorenz1, Mike Barbeck1,2, Robert A Sader1, Charles J Kirkpatrick2, Philippe Russe3, Joseph Choukroun4, Shahram Ghanaati1,2.   

Abstract

Bone substitute materials of different origin and chemical compositions are frequently used in augmentation procedures to enlarge the local bone amount. However, relatively little data exist on the long-term tissue reactions. The presented case reports for the first time histological and histomorphometrical analyses of a nanocrystaline hydroxyapatite-based bone substitute material implanted in the human sinus cavity after an integration period of 3 years. The extracted biopsy was analyzed histologically and histomorphometrically with focus on the tissue reactions, vascularization, new bone formation, and the induction of a foreign body reaction. A comparably high rate of connective tissue (48.25%) surrounding the remaining bone substitute granules (42.13%) was observed. Accordingly, the amount of bone tissue (9.62%) built the smallest fraction within the biopsy. Further, tartrate-resistant acid phosphatase-positive and -negative multinucleated giant cells (4.35 and 3.93 cells/mm(2), respectively) were detected on the material-tissue interfaces. The implantation bed showed a mild vascularization of 10.03 vessels/mm(2) and 0.78%. The present case report shows that after 3 years, a comparable small amount of bone tissue was observable. Thus, the foreign body response to the bone substitute seems to be folded without further degradation or regeneration.

Entities:  

Keywords:  foreign body reaction; multinucleated giant cells; nanobone; osteoclasts

Mesh:

Substances:

Year:  2016        PMID: 26824327     DOI: 10.1563/aaid-joi-D-15-00133

Source DB:  PubMed          Journal:  J Oral Implantol        ISSN: 0160-6972            Impact factor:   1.779


  7 in total

1.  Allogeneic bone block for challenging augmentation-a clinical, histological, and histomorphometrical investigation of tissue reaction and new bone formation.

Authors:  Jonas Lorenz; Alica Kubesch; Sarah Al-Maawi; Frank Schwarz; Robert A Sader; Markus Schlee; Shahram Ghanaati
Journal:  Clin Oral Investig       Date:  2018-03-09       Impact factor: 3.573

2.  Investigation of peri-implant tissue conditions and peri-implant tissue stability in implants placed with simultaneous augmentation procedure: a 3-year retrospective follow-up analysis of a newly developed bone level implant system.

Authors:  Jonas Lorenz; Henriette Lerner; Robert A Sader; Shahram Ghanaati
Journal:  Int J Implant Dent       Date:  2017-09-05

3.  Experimental study of tendon sheath repair via decellularized amnion to prevent tendon adhesion.

Authors:  Chunjie Liu; Kunlun Yu; Jiangbo Bai; Dehu Tian; Guoli Liu
Journal:  PLoS One       Date:  2018-10-16       Impact factor: 3.240

4.  Biological Amnion Prevents Flexor Tendon Adhesion in Zone II: A Controlled, Multicentre Clinical Trial.

Authors:  Chunjie Liu; Jiangbo Bai; Kunlun Yu; Guoli Liu; Siyu Tian; Dehu Tian
Journal:  Biomed Res Int       Date:  2019-04-03       Impact factor: 3.411

5.  Effect of Acellular Amnion With Increased TGF-β and bFGF Levels on the Biological Behavior of Tenocytes.

Authors:  Rongli Sang; Yuanyuan Liu; Lingyu Kong; Ligang Qian; Chunjie Liu
Journal:  Front Bioeng Biotechnol       Date:  2020-05-14

6.  The Effect of Diclofenac Sodium-Loaded PLGA Rods on Bone Healing and Inflammation: A Histological and Histomorphometric Study in the Femur of Rats.

Authors:  Karoline M Reich; Petrus Viitanen; Ehsanul Hoque Apu; Stefan Tangl; Nureddin Ashammakhi
Journal:  Micromachines (Basel)       Date:  2020-12-12       Impact factor: 2.891

7.  Electrospun polycaprolactone (PCL)-amnion nanofibrous membrane prevents adhesions and promotes nerve repair in a rat model of sciatic nerve compression.

Authors:  Ruiyi Dong; Chunjie Liu; Siyu Tian; Jiangbo Bai; Kunlun Yu; Lei Liu; Dehu Tian
Journal:  PLoS One       Date:  2020-12-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.